Atlas Trials

Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens

Clinical trial NCT02191319 · COMPLETED

Trial details

NCT number
NCT02191319
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
HIV Infections
Start date
2002-01-01
Primary completion
2004-08-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.